✦ LIBER ✦

Are Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death?

✍ Scribed by Patrick G. Dean; Jon A. van Heerden; David R. Farley; Geoffrey B. Thompson; Clive S. Grant; W. Scott Harmsen; Duane M. Ilstrup

Publisher: Springer
Year: 2000
Tongue: English
Weight: 121 KB
Volume: 24
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s002680010237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnostic and therapeutic approach to m

Diagnostic and therapeutic approach to multiple endocrine neoplasia type 2B in pediatric patients

✍ M. Torre; G. Martucciello; I. Ceccherini; M. Lerone; M. Aicardi; C. Gambini; V. 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 413 KB

The relationship of the serum gastrin an

The relationship of the serum gastrin and calcium concentrations in patients with multiple endocrine neoplasia type I

✍ M. H. Thompson; D. J. Sanders; E. R. Grund 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Prevalence of multiple endocrine neoplas

Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours

✍ P. Langer; A. Wild; A. Hall; I. Celik; M. Rothmund; D. K. Bartsch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Current approach to the management of ga

Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I

✍ Michel Mignon; Philippe Ruszniewski; Philippe Podevin; Luis Sabbagh; Guillaume C 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 894 KB

A metastatic neuroendocrine anaplastic s

A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111in-pentetreotide

✍ Kenneth J. O'Byrne; Michael G. Goggins; Dermot P. Kelleher; Donald G. Weir; Geor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Extrapulmonary small cell and small cell neuroendocrine tumors of unknown primary site are, in general, aggressive neoplasms with a short median survival. Like small cell lung cancer (SCLC), they often are responsive to chemotherapy and radiotherapy. Small cell lung cancer and well differentiated ne